[go: up one dir, main page]

NO954609L - Niopecotiske syrederivater som antitrombiske forbindelser - Google Patents

Niopecotiske syrederivater som antitrombiske forbindelser

Info

Publication number
NO954609L
NO954609L NO954609A NO954609A NO954609L NO 954609 L NO954609 L NO 954609L NO 954609 A NO954609 A NO 954609A NO 954609 A NO954609 A NO 954609A NO 954609 L NO954609 L NO 954609L
Authority
NO
Norway
Prior art keywords
compounds
niopecotic
antithrombic
acid derivatives
telet
Prior art date
Application number
NO954609A
Other languages
English (en)
Other versions
NO954609D0 (no
NO304885B1 (no
Inventor
Mary Pat Beavers
Patricia Andrade-Gordon
William J Hoekstra
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of NO954609D0 publication Critical patent/NO954609D0/no
Publication of NO954609L publication Critical patent/NO954609L/no
Publication of NO304885B1 publication Critical patent/NO304885B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
NO954609A 1994-03-16 1995-11-15 Nipectoin syrederivater som antitrombe forbindelser NO304885B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21377294A 1994-03-16 1994-03-16
US36489694A 1994-12-27 1994-12-27
PCT/US1995/003145 WO1995025091A2 (en) 1994-03-16 1995-03-14 Nipecotic acid derivatives as antithrombic compounds

Publications (3)

Publication Number Publication Date
NO954609D0 NO954609D0 (no) 1995-11-15
NO954609L true NO954609L (no) 1996-01-05
NO304885B1 NO304885B1 (no) 1999-03-01

Family

ID=26908383

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954609A NO304885B1 (no) 1994-03-16 1995-11-15 Nipectoin syrederivater som antitrombe forbindelser

Country Status (20)

Country Link
US (1) US5770575A (no)
EP (1) EP0746545B1 (no)
JP (1) JPH09510453A (no)
KR (1) KR100328287B1 (no)
CN (1) CN1083834C (no)
AT (1) ATE180470T1 (no)
AU (1) AU703397B2 (no)
CA (1) CA2163027A1 (no)
DE (1) DE69509875T2 (no)
DK (1) DK0746545T3 (no)
ES (1) ES2131313T3 (no)
FI (1) FI113763B (no)
GR (1) GR3030566T3 (no)
HU (1) HUT74871A (no)
MX (1) MX9504800A (no)
NO (1) NO304885B1 (no)
NZ (1) NZ283209A (no)
RU (1) RU2135470C1 (no)
TW (1) TW318179B (no)
WO (1) WO1995025091A2 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW401414B (en) * 1993-09-22 2000-08-11 Fujisawa Pharmaceutical Co <beta>-alanine derivative and a process for the preparation thereof
KR19980703107A (ko) * 1995-03-17 1998-10-15 후지야마 아키라 N-아실피페리디닐카보닐아미노카복실산 및 당단백질 IIB/IIa 길항제와 피브리노겐-혈소판 결합 억제제로서의 이의 용도
CA2248809A1 (en) * 1996-03-13 1997-09-18 Fujisawa Pharmaceutical Co., Ltd. N-[(r)-1-{3-(4-piperidyl)propionyl}-3-piperidylcarbonyl]-2(s)-acetylamino-beta-alanine as fibrinogen receptor antagonist
SI0923555T1 (en) * 1996-05-01 2005-10-31 Ortho-Mcneil Pharmaceutical, Inc. Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
BR9710434A (pt) * 1996-05-01 1999-08-17 Ortho Pharma Corp Derivados de carboxiamida de pirrolidina piperidina e hexahidroazepina para o tratamento de desordens trombÄticas
DE19741235A1 (de) * 1997-09-18 1999-03-25 Hoechst Marion Roussel De Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
US6066651A (en) * 1997-10-29 2000-05-23 Ortho-Mcneil Pharmaceutical, Inc. Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders
AU1415099A (en) * 1997-11-18 1999-06-07 Merck & Co., Inc. 4-substituted-4-piperidine carboxamide derivatives
US6020347A (en) * 1997-11-18 2000-02-01 Merck & Co., Inc. 4-substituted-4-piperidine carboxamide derivatives
EP1165543B1 (en) * 1999-03-22 2003-06-04 Ortho-Mcneil Pharmaceutical, Inc. PROCESS FOR PREPARING S-(R*,S*)] -$g(b) - 1- 1-OXO-3- (4-PIPERIDINYL) PROPYL] -3-PIPERIDINYL] CARBONYL] AMINO] -3- PYRIDINEPROPANOIC ACID AND DERIVATIVES
AUPQ570100A0 (en) * 2000-02-17 2000-03-09 Fujisawa Pharmaceutical Co., Ltd. Beta-alanine derivatives and their use as receptor antagonists
US20070189970A1 (en) 2004-02-25 2007-08-16 Astellas Pharma Inc. Contrast medium for thrombus formation
RU2349304C1 (ru) * 2007-08-10 2009-03-20 Закрытое Акционерное Общество "Канонфарма Продакшн" Таблетированная лекарственная форма клопидогрела или его фармацевтически приемлемой соли, способ ее получения и применение
EP3184149A1 (en) * 2015-12-23 2017-06-28 Julius-Maximilians-Universität Würzburg Soluble glycoprotein v for treating thrombotic diseases
CN109734655B (zh) * 2019-03-11 2020-06-02 都创(上海)医药科技有限公司 一种fkbp配体的同型二聚体合成工艺

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
US5318899A (en) * 1989-06-16 1994-06-07 Cor Therapeutics, Inc. Platelet aggregation inhibitors
TW201303B (no) * 1990-07-05 1993-03-01 Hoffmann La Roche
IE912760A1 (en) * 1990-08-06 1992-02-12 Smith Kline French Lab Compounds
AU3141693A (en) * 1991-11-22 1993-06-15 Friedman, Mark M. Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them
US5219867A (en) * 1991-12-16 1993-06-15 Research Corporation Technologies, Inc. Platelet aggregation inhibitory agents
CA2150371C (en) * 1992-12-11 2002-09-17 Dov Borovsky Materials and methods for control of pests
US5559209A (en) * 1993-02-18 1996-09-24 The General Hospital Corporation Regulator regions of G proteins

Also Published As

Publication number Publication date
EP0746545A1 (en) 1996-12-11
CN1128022A (zh) 1996-07-31
FI955498L (fi) 1996-01-15
AU703397B2 (en) 1999-03-25
HU9503270D0 (en) 1996-05-28
DK0746545T3 (da) 1999-11-08
FI955498A0 (fi) 1995-11-15
AU2119195A (en) 1995-10-03
JPH09510453A (ja) 1997-10-21
RU2135470C1 (ru) 1999-08-27
NO954609D0 (no) 1995-11-15
CA2163027A1 (en) 1995-09-21
US5770575A (en) 1998-06-23
ATE180470T1 (de) 1999-06-15
GR3030566T3 (en) 1999-10-29
TW318179B (en) 1997-10-21
ES2131313T3 (es) 1999-07-16
HUT74871A (en) 1997-02-28
DE69509875T2 (de) 1999-12-09
CN1083834C (zh) 2002-05-01
WO1995025091A2 (en) 1995-09-21
EP0746545B1 (en) 1999-05-26
KR100328287B1 (ko) 2002-10-11
NZ283209A (en) 1998-04-27
FI113763B (fi) 2004-06-15
NO304885B1 (no) 1999-03-01
MX9504800A (es) 1997-05-31
DE69509875D1 (de) 1999-07-01
WO1995025091A3 (en) 1995-10-12

Similar Documents

Publication Publication Date Title
NO971538L (no) Purin- og guaninforbindelser som inhibitorer for PNP
NO954609L (no) Niopecotiske syrederivater som antitrombiske forbindelser
BR9900177A (pt) Inibidores de metaloprotease.
DK0560268T3 (da) Substituerede pipecolinsyrederivater som HIV-proteasehæmmere
PT896533E (pt) Pentafluorobenzenosulfonamidas e analogos
DK0594702T3 (da) Substituerede indoler som midler mod AIDS
NO963370L (no) Nye mercaptoacetylamido-1,3,4,5-tetrahydrobenzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
PT923554E (pt) N-benzilpiperidina e derivados tetrahidropiridina
EA200200510A1 (ru) 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр
EA200000826A1 (ru) Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы
EA200000204A1 (ru) Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов
NO972887D0 (no) Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel
NO20022977D0 (no) Substituerte homopiperidinylbenzimidazolanaloger som fundiske relaksanter
MX9603348A (es) Derivados de disulfuro de amida indano-2-mercaptoacetilica novedosos utiles como inhibidores de encefalinasa.
DE69527854D1 (de) Derivate substituierter amidinonaphthylester
FI960588A0 (fi) Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä
NO995132D0 (no) Fremgangsmåte for reduksjon av fibrinogen
GT199400074A (es) Pirroles substituidos
AR005835A1 (es) Derivados aromaticos sustituidos del acido fosfonico.
NO20012328D0 (no) Fluorerte 3,4-dihydrokinolinderivater anvendt som NOS- inhibitorer